The Pharma Data

FEBRUARY 12, 2022

The approval extends the current indication in China as add-on therapy in adults and children aged five years and older with active systemic lupus erythematosus (SLE). positive anti-double-stranded DNA and low complement, and an objective assessment of overall disease activity using SELENA-SLEDAI score ? 8) despite standard therapy.

Production 52

Production Therapies Trials Disease 52

Drug Target Review

OCTOBER 4, 2023

2 In response, DNA-damaging agents that could target the entire cell cycle received renewed attention as ADC payloads. 10 Proteasome inhibitors Since the approval of Bortezomib in 2003, 11 new proteasome inhibitors have emerged with reduced side effects. These developments give researchers the tools to craft better therapeutics.

Small Molecule 126

Small Molecule Drugs Immune Response Targeted Protein Degradation 126

Codon

DECEMBER 17, 2023

Recombinant DNA technologies were invented in the 1970s. A first draft of the human genome was completed in 2003. At least six CAR-T cancer therapies have now garnered F.D.A. Laundry may not be as immediately headline-grabbing as new cancer therapies, but it provides a concrete and ingenious solution to a demonstrable need.

Engineering 52

Engineering Molecular Biology Doctors DNA 52